Sign In
Buy TXG
$31.75
-0.470 (-1.46%)
At Close: Jun 16, 2026
A Deep Dive Into 10x Genomics, A Promising Portfolio
01:53am, Thursday, 06'th Apr 2023
10x Genomics develops cutting-edge platforms for single-cell and spatial analysis, driving advances in disease research and drug discovery. Despite market fluctuations, their strong product pipeline i
Investment in procedural medical devices is safer for valuation, says E Squared's Les Funtleyder
02:12pm, Thursday, 30'th Mar 2023
Les Funtleyder, portfolio manager for E Squared Capital Management, joins 'The Exchange' to discuss big cap pharma's Q1 performance, the dollar weakness contributing to biotech gains, and investment o
10x Genomics to Present at the 43rd Annual Cowen Healthcare Conference
04:30pm, Wednesday, 22'nd Feb 2023
PLEASANTON, Calif. , Feb. 22, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the company will be pa
10x Genomics, Inc. (TXG) Q4 2022 Earnings Call Transcript
09:49pm, Wednesday, 15'th Feb 2023
10x Genomics, Inc. (NASDAQ:TXG ) Q4 2022 Earnings Conference Call February 15, 2023 4:30 PM ET Company Participants Cassie Corneau - Head, Investor Relations & Strategic Finance Serge Saxonov - Chief
10x Genomics (TXG) Reports Q4 Loss, Tops Revenue Estimates
06:49pm, Wednesday, 15'th Feb 2023
10x Genomics (TXG) delivered earnings and revenue surprises of 48.28% and 6.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
3 CRISPR Stocks to Buy Now Or You'll Be Kicking Yourself Later
12:58pm, Thursday, 02'nd Feb 2023
CRISPR is an acronym which refers to a series of DNA sequences in bacteria and other organisms. Scientists have begun editing genes, including CRISPR, to try to improve human health.
Cathie Wood Is Crushing It This Year Thanks To 9 Stocks
08:00am, Friday, 20'th Jan 2023
Cathie Wood's ARK Innovation ETF is back — and back big. It's the top diversified ETF again this year so far, largely due to big winners.
10x Genomics to Report Fourth Quarter and Full Year 2022 Financial Results on February 15, 2023
04:05pm, Thursday, 19'th Jan 2023
PLEASANTON, Calif. , Jan. 19, 2023 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the fourth quarter and full year ended December 31, 2022 after market
3 Medical Info Systems Stocks Braving Industry-wide Headwinds
05:17am, Tuesday, 17'th Jan 2023
Zacks Medical Info Systems industry stocks like 10x Genomics (TXG), NextGen Healthcare (NXGN) and Health Catalyst (HCAT) are expected to gain as COVID-19 severity fades.
10x Genomics toolkit ‘at the fulcrum of innovation,' CEO says
05:00am, Saturday, 14'th Jan 2023
This segment originally aired on January 10, 2023. 10x Genomics CEO Serge Saxonov joins Yahoo Finance live anchor Rachell Akuffo to discuss biotechnology innovation, progress in genomics, and macroeco
10x Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference
04:05pm, Wednesday, 28'th Dec 2022
PLEASANTON, Calif. , Dec. 28, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the company will be
10x Genomics: Long-Term Growth Potential Marred By Near-Term Funding Risks
10:05pm, Tuesday, 27'th Dec 2022
10x Genomics is targeting larger addressable market opportunities over the mid to long term. The accelerated Xenium launch will bolster the growth potential but may be insufficient to plug a looming s
These Were the 5 Best and Worst Performing Mid-Cap Stocks in November 2022
10:52pm, Monday, 12'th Dec 2022
The stock market witnessed an upward trend last month, a continuation from October.
Torex Gold Resources Inc. (TORXF) Q3 2022 Earnings Call Transcript
03:26pm, Thursday, 10'th Nov 2022
Torex Gold Resources Inc. (OTCPK:TORXF) Q3 2022 Earnings Conference Call November 10, 2022 9:00 AM ET Company Participants Dan Rollins - Senior Vice President, Corporate Development & Investor Relatio
10x Genomics, Inc. (TXG) Q3 2022 Earnings Call Transcript
10:14pm, Wednesday, 02'nd Nov 2022
10x Genomics, Inc. (NASDAQ:TXG ) Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Cassie Corneau - Head, Investor Relations & Strategic Finance Serge Saxonov - Chief E
